Celltrion reported record-high revenue for the first quarter of 2025, with consolidated sales reaching 841.9 billion won ...

Korea's Daewon Pharmaceutical said Monday it is moving forward with a phase 3 program for DW4421, a potassium-competitive ...

Celltrion is drawing a hard line between what built its business and what comes next. At its first-ever booth at BIO KOREA, ...

ST Pharm is laying the groundwork for large-scale RNA production, with plans to expand oligonucleotide and mRNA manufacturing ...

The Korean biotech that sold its brain drug shuttle to GSK for 4.1 billion won ($2.9 billion) isn’t celebrating. It’s ...

CHA Medical Group and CHA University have opened discussions with Johns Hopkins Medicine International to explore potential ...

The Dong-Eun Medical Museum at Yonsei University College of Medicine has recently released rare film footage of medical ...

Neurophet, a medical AI imaging company, said it has received preliminary approval from the Korea Exchange for a listing on ...

Global pharmaceutical giant MSD is accelerating its open innovation strategy in Korea, highlighting its growing number of ...

EOFlow, the Korean medtech company known for developing Korea’s first and the world’s second wearable insulin pump, has lost ...

I've recently been on a TV show called “To Live, I Run.” It's a show that brings together a group of novice runners and ...

Therapex, which has demonstrated clinical capabilities with small molecules, is now expanding into degrader antibody ...